CNS, Cardiometabolics A Bright Spot In Recent Chinese VC/PE Fundings

Overall Fundraising Still Muted

funding
VC and PE-backed fundings for Chinese biotechs remained lukewarm over the period from February to April. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Business